Use of urea-adjuvated polypeptides for diagnosis,...

Details Use of urea-adjuvated polypeptides for diagnosis,... Use of urea-adjuvated polypeptides for diagnosis,...

2003-03-19

2010-11-09

Juedes, Amy E (Department: 1644)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Primate cell, per se

C435S373000

Reexamination Certificate

active

07829331

ABSTRACT:
The invention relates to a method for infiltration of polypeptides in cells. The invention further relates to the use of the cells and urea-adjuvated polypeptides for the diagnosis, treatment or prevention of diseases. The invention further relates to the detection of polypeptide-specific immune cells.

REFERENCES:
patent: 1 128 005 (1968-09-01), None
Prabhakar et al., 1997, Urea inhibits inducible nitric oxide synthase in macrophage cell line. Am. J. Phys. vol. 273: 1882-1888.
“Liquor” Stedmans medical dictionary 27thedition, 2000. Doucett et al., 2005, J. Immunol. Methods, vol. 303: 40-52.
Pala et al., 2000, J. Immunol. Methods, vol. 243: 107-24.
Broff et al., 1981, Eur. J. Immunol. vol. 11: 365-71.
Van Kaer et al., 2005, Curr Biol. vol. 15:R429-31.
Sone et al., 1998, J. Immunol. vol. 161: 448-457.
Kessler et al., 1999, Clinical Chemistry, vol. 45: 1523-1529.
Invitrogen Technical Resources-Medial Formulations, 2008, pp. 1-3.
Schenk et al., 1995, J. Allergy Clin. Immunol. vol. 96: 986-996.
Sheil et al., 1992, J. Exp. Med. vol. 175: 545-552.
Kerblat et al., 2000, immunology, vol. 100: 178-184.
Nagahara et al., 1998, Nat. Med. vol. 4: 1449-1452.
Bauer et al.,“Induction of MHC class-I and -II restricted epitope presentation by urea-treated BZLF1 protein: a novel technology for the detection of protein-specific cytotoxic t-cells,”Proceedings of the EBV2002 Conference, p. 34, 2002.
Elliot et al., “Dominant cytotoxic T Lymphocyte response to the immediate-earlytrans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection,”Journal of Infectious Diseases, 176:1068-1072, 1997.
Jenne et al., “Viral vectors for dendritic cell-based immunotherapy,”Trends Immunol., 22(2):102-107, 2001.
Mi et al., “Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo,”Mol. Ther. 2(4):339-347, 2000.
O'Hagan et al., “Recent developments in adjuvants for vaccines against infectious diseases,”Biomol Engin., 18:69-85, 2001.
Schirmbeck et al., “Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo,”Eur. J. Immunol., 24:2068, 1994.
Schirmbeck et al., “Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens,”Vaccine, 13:857-865, 1995.
Schwarze et al., “Protein transduction: unrestricted delivery into all cells?”Trends CellBiol. 10:290, 2000.
Sester et al., “Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection,”AIDS, 14:2653-60), 2000.

Affiliated with

Also associated with

Rating

Use of urea-adjuvated polypeptides for diagnosis,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of urea-adjuvated polypeptides for diagnosis,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of urea-adjuvated polypeptides for diagnosis,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4174170